Intravenous Lidocaine to Prevent Post-Fundal Pressure Headache During Cesarean Section
Condition(s) studied
Investigational drug(s) / intervention(s)
Lidocaine IV: IV lidocaine 1.5 mg/kg (diluted with 0.9% isotonic saline to a total volume of 10 ml) over 5 minutes with the start of skin incision after ensuring negative baseline headache.
Saline 0.9%: IV 10 ml isotonic saline over 5 minutes with the start of skin incision after ensuring negative baseline headache.
Study summary
This prospective randomized controlled multicenter study will be conducted to evaluate the effects of pre-emptive IV lidocaine dose on the incidence and severity of intraoperative headache that may occur after the extra-abdominal manual uterine fundal pressure in patients undergoing cesarean section under spinal anesthesia.
Eligibility
Primary outcome measure(s)
- Incidence of intraoperative headache — Up to the end of surgery.
The incidence of intraoperative headache that may occur after fundal pressure application until the end of surgery will be recorded.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Tanta University Hospitals | Tanta | Gharbia Governorate | Recruiting |
More Tanta University trials in Egypt
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07661758 on ClinicalTrials.gov ↗ ← All trials in Egypt